In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
The U.S. Food and Drug Administration reports the number of Thoroughbreds who died after receiving a compounded drug from Wickliffe Pharmacy in Lexington, Ky. has grown to four, and six others have become ill.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
Scientists are warning horse owners and veterinarians to be cautious about using compounded (private pharmacy-mixed) gastric ulcer medications.
Most Popular Stories
- Dortmund Could Return in Triple Bend
- Irish War Cry Ticks All the Boxes in Five-Furlong Work
- Winx Soars to Fifteenth Straight Win
- Veteran Kentucky-Based Hot Walker Roche Dies at 91
- Weekend Stakes Rundown: Fair Grounds in the Spotlight
- Broken Pelvis Cause of Charismatic's Death
- Farrell Vaults to Top of Kentucky Oaks Leaderboard
- Tapits Dominate Fasig-Tipton Pinhook Prospects
- Honorable Duty Holds Strong in Mineshaft Handicap
- Horse of the Year Charismatic Dies